Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Loading Pathway...

Prostaglandin G/H synthase 2 Prostaglandin E synthase Prostacyclin synthase Thromboxane-A synthase Cytosolic phospholipase A2 Prostaglandin G/H synthase 1 Prostaglandin G/H synthase 1 Docosahexaenoic acid Eicosapentaenoic acid Docosahexaenoic acid Docosahexaenoic acid Eicosapentaenoic acid Eicosapentaenoic acid Prostaglandin H2 Prostaglandin E2 Prostaglandin I2 Thromboxane A2 Arachidonic acid O2 Prostaglandin G2 H2O Glutathione Heme Heme Phospholipids Acceptor Reduced acceptor Prostaglandin G/H synthase 2 Heme Heme Heme Heme Calcium Endoplasmic Reticulum Cytosol Blood Vessel DHA and EPA inhibit COX-2 (prostaglandin G/H synthase 2) on the endoplasmic reticulum membrane, preventing the conversion of arachidonic acid into PGH2. Prostaglandin H2 synthesis is reduced COX-1 synthesizes prostaglandins necessary for normal gastrointestinal and renal function. COX-2 is responsible for prostaglandin synthesis during tissue injury and inflammation. Inhibition of COX-2 provides anti-inflammatory activity. Prostaglandin E2 is responsible for inflammation and pain by activating immune cells and stimulating pain fibres. Lower concentrations of prostaglandin E2 lowers inflammatory and pain response, hence an analgesic effect is seen. Decreasing PGE2 in the central nervous system also has an antipyretic effect. Inflamed cell
Endoplasmic Reticulum PTGS2 PTGES PTGIS TBXAS1 PLA2G4A PTGS1 PTGS1 Docosahexaenoic acid Eicosapentaenoic acid Docosahexaenoic acid Docosahexaenoic acid Eicosapentaenoic acid Eicosapentaenoic acid Prostaglandin H2 Prostaglandin E2 Prostaglandin I2 Thromboxane A2 Arachidonic acid Oxygen Prostaglandin G2 Water Phospholipids Acceptor Reduced acceptor PTGS2
PTGS2 PTGES PTGIS TBXAS1 PLA2G4A PTGS1 PTGS1 DHA EPA DHA DHA EPA EPA PGH2 PGE2 PrstgI2 ThrmbA2 20:4 O2 PGG2 H2O GSH Heme Heme Phosp Accepto RA PTGS2 Heme Heme Heme Heme Ca2+ Endoplasmic Reticulum Cytosol Blood Vessel DHA and EPA inhibit COX-2 (prostaglandin G/H synthase 2) on the endoplasmic reticulum membrane, preventing the conversion of arachidonic acid into PGH2. Prostaglandin H2 synthesis is reduced COX-1 synthesizes prostaglandins necessary for normal gastrointestinal and renal function. COX-2 is responsible for prostaglandin synthesis during tissue injury and inflammation. Inhibition of COX-2 provides anti-inflammatory activity. Prostaglandin E2 is responsible for inflammation and pain by activating immune cells and stimulating pain fibres. Lower concentrations of prostaglandin E2 lowers inflammatory and pain response, hence an analgesic effect is seen. Decreasing PGE2 in the central nervous system also has an antipyretic effect. Inflamed cell
Endoplasmic Reticulum PTGS2 PTGES PTGIS TBXAS1 PLA2G4A PTGS1 PTGS1 DHA EPA DHA DHA EPA EPA PGH2 PGE2 PrstgI2 ThrmbA2 20:4 O2 PGG2 H2O Phosp Accepto RA PTGS2